Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-11-22
2005-11-22
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S376000, C544S231000
Reexamination Certificate
active
06967201
ABSTRACT:
The present invention provides serotonergic benzofurylpiperazines of Formula I:where:A is a piperazine of formula:and R, R1, R2, R3, R4, R5, R5′, R6, R6′, R7, R7′, R8, and R8′are as described in the specification.
REFERENCES:
patent: 5698766 (1997-12-01), Julius et al.
patent: 6638936 (2003-10-01), Briner et al.
patent: 0 006 524 (1980-01-01), None
patent: 0 189 612 (1986-08-01), None
patent: WO 95 11243 (1995-04-01), None
patent: WO 97 08167 (1997-03-01), None
patent: WO 97 36893 (1997-10-01), None
Kuipers W. et al: “N4-unsubstituted 1-6 nl-arylpiperazines as high-affinity 5-HT1A recept r ligands” Journal of Medicinal Chemistry., vol. 38, No. 11, May 26, 1995, pp. 1942-1954, XP002153536 American Chemical Society. Washington., US ISSN: 0022-2623.
Briner Karin
Burkhart Joseph Paul
Burkholder Timothy Paul
Cunningham Brian Eugene
Fisher Matthew Joseph
Bernhardt Emily
Eli Lilly and Company
Tucker R. Craig
LandOfFree
Benzofurylpiperazines and benzofurylhomopiperazines:... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzofurylpiperazines and benzofurylhomopiperazines:..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzofurylpiperazines and benzofurylhomopiperazines:... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3491742